GR3036725T3 - Container with freeze-dried vaccine components - Google Patents

Container with freeze-dried vaccine components

Info

Publication number
GR3036725T3
GR3036725T3 GR20010401579T GR20010401579T GR3036725T3 GR 3036725 T3 GR3036725 T3 GR 3036725T3 GR 20010401579 T GR20010401579 T GR 20010401579T GR 20010401579 T GR20010401579 T GR 20010401579T GR 3036725 T3 GR3036725 T3 GR 3036725T3
Authority
GR
Greece
Prior art keywords
container
freeze
vaccine
vaccine components
dried vaccine
Prior art date
Application number
GR20010401579T
Other languages
English (en)
Inventor
Antonius Theodorus Wilderbeek
Hans Almer Middelbeek
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of GR3036725T3 publication Critical patent/GR3036725T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
GR20010401579T 1996-03-07 2001-09-27 Container with freeze-dried vaccine components GR3036725T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07
EP97200647A EP0799613B1 (en) 1996-03-07 1997-03-05 Vaccine pack comprising a container with freeze-dried vaccine components

Publications (1)

Publication Number Publication Date
GR3036725T3 true GR3036725T3 (en) 2001-12-31

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401579T GR3036725T3 (en) 1996-03-07 2001-09-27 Container with freeze-dried vaccine components

Country Status (19)

Country Link
US (2) US5897852A (el)
EP (1) EP0799613B1 (el)
JP (1) JP4293643B2 (el)
KR (1) KR100458370B1 (el)
CN (1) CN1133423C (el)
AT (1) ATE202925T1 (el)
AU (1) AU704629B2 (el)
CA (1) CA2198195C (el)
DE (1) DE69705569T2 (el)
DK (1) DK0799613T3 (el)
EG (1) EG23992A (el)
ES (1) ES2161412T3 (el)
GR (1) GR3036725T3 (el)
HU (1) HU220532B1 (el)
IL (1) IL120202A (el)
NZ (1) NZ314267A (el)
PT (1) PT799613E (el)
SA (1) SA97170715B1 (el)
ZA (1) ZA971734B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
AU779403B2 (en) * 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
US20140248273A1 (en) 2001-09-08 2014-09-04 Jos van Strijp Vaccine based on staphylococcal superantigen-like 3 protein (ssl3)
RU2006126051A (ru) * 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
EP2658568A1 (en) 2010-12-29 2013-11-06 Intervet International B.V. Canine babesiosis vaccine antigen
WO2013066769A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Methods of preparing lyophilized spherical-shaped pellets of biological materials
US10617650B2 (en) * 2015-10-16 2020-04-14 Merck Sharp & Dohme Corp. Process for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
SE425461B (sv) * 1971-09-03 1982-10-04 Du Pont Sett att framstella en homogen, lyofiliserad produkt av blodserum eller blodplasma
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US5044091B1 (en) * 1989-04-18 1997-12-30 Sankyo Co Method of preparing a freeze-dried formulation of a drug
CA2030551C (en) * 1989-05-01 1998-08-25 Wayne Gombotz Process for producing small particles of biologically active molecules
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
JPH08509483A (ja) * 1993-04-28 1996-10-08 アクゾ・ノベル・エヌ・ベー ゴナドトロピンを含有するライオスフィア
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
HU9700556D0 (en) 1997-04-28
KR970064584A (ko) 1997-10-13
ATE202925T1 (de) 2001-07-15
NZ314267A (en) 1998-01-26
JPH1024090A (ja) 1998-01-27
ES2161412T3 (es) 2001-12-01
KR100458370B1 (ko) 2005-07-07
DK0799613T3 (da) 2001-10-22
EP0799613B1 (en) 2001-07-11
US5897852A (en) 1999-04-27
AU1514997A (en) 1997-09-11
ZA971734B (en) 1997-09-09
CN1133423C (zh) 2004-01-07
HUP9700556A3 (en) 2000-04-28
DE69705569T2 (de) 2002-05-16
IL120202A0 (en) 1997-06-10
EP0799613A1 (en) 1997-10-08
PT799613E (pt) 2001-12-28
IL120202A (en) 2001-03-19
AU704629B2 (en) 1999-04-29
CA2198195C (en) 2005-10-25
CA2198195A1 (en) 1997-09-07
CN1163102A (zh) 1997-10-29
JP4293643B2 (ja) 2009-07-08
EG23992A (en) 2008-03-09
HUP9700556A2 (en) 1997-12-29
US6106836A (en) 2000-08-22
DE69705569D1 (de) 2001-08-16
HU220532B1 (hu) 2002-03-28
SA97170715B1 (ar) 2006-10-11
MX9701726A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
EG23992A (en) Container with freeze-dried vaccine components
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
IL109056A0 (en) Vaccine compositions
ZA976285B (en) Bovine polynucleotide vaccine for the intrademal route
PH31297A (en) Antiperspirant aerosol composition with high solids content.
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
EP0610629A3 (en) Curable organopolysiloxane compositions.
EP0700684A3 (de) Zusammensetzungen, enthaltend Prothrombinkomplex-Konzentrat und wenigstens eine weitere Komponente das die Blutgerrinnung fördert, als Gegenmittel für Blut-Anticoagulanzien
ZA943316B (en) Process for the preparation of microballs and microballs thus obtained.
AU5639390A (en) Gangliotetraosylceramide as an adsorbent for enteric viral pathogens
GB9326425D0 (en) Vaccine compositions
EP0444605A3 (en) Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof
AR244690A1 (es) Compuestos con grupos triazol,tetrahidrofurano y fenilo,composicion fungicida que los contiene,procedimiento de preparacion de dichos compuestos y compuestos intermedios utilizados en los mismos.
EP0634335A3 (en) Foot to add a box to a box pallet.
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
AP2000001746A0 (en) Anti- first-pass effect compounds.
EP0402160A3 (en) Amine-alkylborane derivatives and methods
IL100221A0 (en) Compositions based on polyphosphazene,particularly for floor covering
SI0793495T1 (en) Freeze-dried ondansetron compositions
AU7954487A (en) Arrangement for drying shoes, skiboots or the like
TW324944U (en) Electrothermal component structure for rapidly generating vapor
IT1263170B (it) Composizione antiemorroidale
NO944540D0 (no) Brett, samt fremgangsmåte for fylling av slikt brett
ZA9711412B (en) Method for increasing the charring ratio of coal
SI0925234T1 (en) Two component containers